{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:06:03Z","timestamp":1781103963558,"version":"3.54.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5448,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1046\/j.1365-2133.2000.03787.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T09:45:22Z","timestamp":1027676722000},"page":"843-845","source":"Crossref","is-referenced-by-count":162,"title":["Imiquimod: a novel treatment for lentigo maligna"],"prefix":"10.1093","volume":"143","author":[{"given":"I.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berth-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"issue":"Suppl. 1","key":"10.1046\/j.1365-2133.2000.03787.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S0923-1811(98)84271-0","article-title":"Safety and efficacy of Imiquimod 5% cream for the treatment of Bowen\u2019s disease","volume":"16","author":"Mackenzie-Wood","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiqimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jlb.55.2.234","article-title":"Cytokine induction in mice by the immunomodulator imiquimod","volume":"55","author":"Reiter","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(196805)21:5<893::AID-CNCR2820210513>3.0.CO;2-8","article-title":"Melanotic freckle of Hutchinson","volume":"21","author":"Wayte","year":"1968","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB5|cit5","first-page":"39","article-title":"Lentigo maligna and lentigo maligna melanoma","volume":"55","author":"Clark","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1524-4725.1979.tb00016.x","article-title":"Treatment of lentigo maligna and lentigo maligna melanoma","volume":"5","author":"Pitman","year":"1979","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1524-4725.1980.tb00900.x","article-title":"Treatment of lentigo maligna and lentigo maligna melanoma","volume":"6","author":"Coleman","year":"1980","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/1097-0142(19940615)73:12<2964::AID-CNCR2820731213>3.0.CO;2-O","article-title":"Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs\u2019 micrographic surgery aided by rush permanent sections","volume":"73","author":"Cohen","year":"1994","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0011-2240(79)90048-8","article-title":"Sensitivity of pigment mucosa and skin to freeze injury","volume":"16","author":"Gage","year":"1979","journal-title":"Cryobiology"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.1997.tb01089.x","article-title":"Treatment of lentigo maligna","volume":"38","author":"Gaspar","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB11|cit11","first-page":"49","article-title":"Ten years\u2019 experience of treating lentigo maligna with topical azelaic acid","volume":"143","author":"Nazzaro-Porro","year":"1989","journal-title":"Acta Derm Venereol (Suppl) (Stockh)"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archderm.1991.01680010141034","article-title":"No effect of topical tretinoin on lentigo maligna","volume":"127","author":"Rivers","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0190-9622(84)80310-2","article-title":"Argon laser treatment of lentigo maligna","volume":"10","author":"Arndt","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1995.01690180115026","article-title":"Treatment of lentigo maligna with carbon dioxide laser","volume":"131","author":"Kopera","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0194-5998(99)70265-2","article-title":"Q-switched neodymium: yttrium-aluminum-garnet laser treatment of lentigo maligna","volume":"120","author":"Orten","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03787.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1097-0142(19880315)61:6<1071::AID-CNCR2820610603>3.0.CO;2-T","article-title":"Intralesional interferon-alpha therapy in advanced malignant melanoma","volume":"61","author":"von Wussow","year":"1988","journal-title":"Cancer"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2000.03787.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03787.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:30:28Z","timestamp":1676377828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/143\/4\/843\/6688147"}},"subtitle":["IMIQUIMOD FOR LENTIGO MALIGNA"],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03787.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}